Form 4: GE HealthCare Executive Thomas Westrick Reports Stock Transactions
SEC Form 4 Filing
Thomas Westrick, CEO of Patient Care Solutions at GE HealthCare Technologies Inc., reports the withholding of shares for tax obligations and the award of restricted stock units and employee stock options.
Summary
- On March 1, 2024, Thomas Westrick, CEO of Patient Care Solutions at GE HealthCare Technologies Inc., reported several transactions involving GE HealthCare common stock.
- Shares were withheld to cover tax obligations related to the vesting of restricted stock units and performance stock units.
- Westrick was also awarded 2,965 restricted stock units, which will vest in three tranches on September 1, 2025, September 1, 2026, and September 1, 2027.
- Additionally, Westrick received an employee stock option for 8,435 shares, also vesting in three tranches on the same dates as the restricted stock units.
- The price of the stock when shares were withheld was $91.28.
- The exercise price of the employee stock option is $92.72.
Sentiment
Score: 6
Explanation: The document is a routine regulatory filing detailing stock transactions. It doesn't contain overtly positive or negative information, reflecting standard executive compensation practices.
Positives
- The award of restricted stock units and employee stock options aligns Westrick's interests with the long-term performance of GE HealthCare.
- The vesting schedule of the awards encourages continued service and commitment from the executive.
Future Outlook
The restricted stock units and stock options vest over a three-year period, indicating a long-term incentive structure.
Industry Context
Executive compensation packages often include stock options and restricted stock units to align management's interests with those of shareholders. This filing reflects a standard practice in publicly traded companies.
Comparison to Industry Standards
- Stock option grants and restricted stock units are common components of executive compensation packages in the healthcare technology industry.
- Companies like Siemens Healthineers and Philips also utilize similar equity-based compensation to incentivize their executives.
- The vesting schedules and exercise prices are generally structured to reward long-term value creation for shareholders.
Stakeholder Impact
- The transactions have a minor impact on shareholders, primarily through potential dilution upon the exercise of stock options and vesting of restricted stock units.
- The equity-based compensation aims to align management's interests with shareholder value creation.
Key Dates
| Date | Description |
|---|---|
| 03/01/2024 | Date of the reported transactions: withholding of shares for tax obligations and award of restricted stock units and employee stock options. |
| 03/05/2024 | Date of signature on the Form 4 filing. |
| 09/01/2025 | First vesting date (33%) for the restricted stock units and employee stock options. |
| 09/01/2026 | Second vesting date (33%) for the restricted stock units and employee stock options. |
| 09/01/2027 | Final vesting date (34%) for the restricted stock units and employee stock options. |
| 03/01/2034 | Expiration date for the employee stock option. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.